Crucially, Lupin is the exclusive first-to-file applicant for this product and is eligible for 180-day generic drug exclusivity in the U.S. market
The approved product is the generic equivalent of Sutab® Tablets developed by Azurity Pharmaceuticals
Strong domestic and international growth, improving product mix, and operational efficiencies drive margin expansion despite exceptional charges impacting quarterly profit
PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion
In his new role, Shisher will lead Glenmark’s marketing initiatives, focusing on strengthening brand positioning, driving market expansion, and accelerating growth
The move signals a major expansion milestone for the Swiss laboratory automation company
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
Revenue from operations climbed 13% to Rs. 886.87 crore
Expands Davaindia network to 2,579 stores
New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain
Subscribe To Our Newsletter & Stay Updated
